IVRO Stock Chart & Stats
$0.08
$0.00(0.00%)
At close: 4:00 PM EDT
$0.08
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.03 - $0.16
Previous CloseN/A
Volume8.57K
Average Volume (3M)17.07K
Market Cap
$1.55M
Enterprise Value$392.35K
Total Cash (Recent Filing)$1.23M
Total Debt (Recent Filing)$240.30K
Price to Earnings (P/E)18.6
Beta-0.69
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding22,159,810
10 Day Avg. Volume3,595
30 Day Avg. Volume17,065
Financial Highlights & Ratios
PEG Ratio0.75
Price to Book (P/B)0.82
Price to Sales (P/S)1.54
P/FCF Ratio-156.26
Enterprise Value/Market Cap0.25
Enterprise Value/Revenue0.51
Enterprise Value/Gross Profit0.62
Enterprise Value/Ebitda7.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IVRO FAQ
What was InVitro International’s price range in the past 12 months?
InVitro International lowest stock price was $0.03 and its highest was $0.16 in the past 12 months.
What is InVitro International’s market cap?
InVitro International’s market cap is $1.55M.
When is InVitro International’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were InVitro International’s earnings last quarter?
InVitro International released its earnings results on May 02, 2024. The company reported $0.002 earnings per share for the quarter.
Is InVitro International overvalued?
According to Wall Street analysts InVitro International’s price is currently Overvalued.
Does InVitro International pay dividends?
InVitro International does not currently pay dividends.
What is InVitro International’s EPS estimate?
InVitro International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InVitro International have?
InVitro International has 22,159,810 shares outstanding.
What happened to InVitro International’s price movement after its last earnings report?
InVitro International reported an EPS of $0.002 in its last earnings report. Following the earnings report the stock price went up 17.647%.
Which hedge fund is a major shareholder of InVitro International?
Currently, no hedge funds are holding shares in IVRO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
InVitro International
Established in 1985 and headquartered in Placentia, California, InVitro International specializes in creating and supplying non-animal testing kits to markets both within the United States and globally. Key among their offerings is the Irritection Assay System, an in vitro diagnostic tool designed to identify, categorize, and forecast the potential for eye and skin irritation across a broad spectrum of items, including cosmetics, general consumer products, pharmaceuticals, and various chemical raw materials. They also provide Corrositex, another in vitro test specifically for determining chemical corrosiveness. Beyond product sales, the company delivers tailored technological support for the implementation and use of the Irritection system, alongside offering independent laboratory services for irritation and corrosion assessments. Their solutions are predominantly adopted by manufacturers involved in producing surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials.